{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T12:11:42Z","timestamp":1763035902306,"version":"3.40.5"},"reference-count":22,"publisher":"American Academy of Pediatrics (AAP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,4,1]]},"abstract":"<jats:p>Background. Hypoxic ventilatory depression in mice and muscle fatigue in adult humans are improved by creatine supplementation (CS). Because these issues may be operative in apnea of prematurity (AOP), we hypothesized that CS reduces episodes of hypoxemia and bradycardia in infants with AOP.<\/jats:p>\n               <jats:p>Methods. Infants were eligible for this double-blind, controlled trial if gestational age was &amp;lt;32 weeks and AOP was severe enough to require treatment with caffeine. If they had \u22651 desaturation (pulse oximeter saturation [SpO2] \u2264 80%) or bradycardia (heart rate \u2264 two thirds of baseline) per hour in an initial 6-hour recording, they were randomized to a 2-week course of oral CS (200 mg\/kg per day) or placebo (P). Infants then underwent 2 additional 6-hour recordings of breathing movements, nasal airflow, heart rate, pulse oximeter saturation (SpO2) and pulse waveforms after 7 and 14 days of treatment. Urinary creatine excretion was measured also. Recordings were analyzed for the frequency of bradycardia and desaturation, the primary outcome parameter, as well as for apnea (\u226510 seconds), baseline heart and respiratory rate, and SpO2.<\/jats:p>\n               <jats:p>Results. Of 38 infants enrolled, 34 completed the study (17 in each group). Median (range) gestational age at birth was 27 (25\u201330) vs 27 (25\u201330) weeks, and at study 29 (26\u201336) vs 29 (27\u201333) weeks. Oral CS was well tolerated; no side effects were noted. Urinary creatine excretion was low in the P group (median: 27 mmol\/mol of creatinine; range: 18\u2013102) and increased in the CS group (6949 mmol\/mol of creatinine; range: 1427\u201311807). CS, however, had no effect on the combined rate of bradycardia and desaturation (P: 2.7 per hour [range: 0.2\u201310.3]; CS: 4.1 per hour [range: 0.6\u201312.1]), nor was there any decrease in apnea rate (P: 1.7 per hour [range: 0\u20134.5]; CS: 2.2 per hour [range: 0.2\u20135.1]).<\/jats:p>\n               <jats:p>Conclusion. Despite a significant increase in creatine excretion, suggesting good enteral absorption, CS did not, in the dose and for the duration given in this study, improve symptoms of AOP in these infants.<\/jats:p>","DOI":"10.1542\/peds.113.4.e303","type":"journal-article","created":{"date-parts":[[2004,8,14]],"date-time":"2004-08-14T00:53:04Z","timestamp":1092444784000},"page":"e303-e307","source":"Crossref","is-referenced-by-count":26,"title":["Randomized, Controlled Trial of Oral Creatine Supplementation (Not Effective) for Apnea of Prematurity"],"prefix":"10.1542","volume":"113","author":[{"given":"Bettina","family":"Bohnhorst","sequence":"first","affiliation":[{"name":"Department of Neonatology and Pediatric Pulmonology, Hannover Medical School, Hannover, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiana","family":"Geuting","sequence":"additional","affiliation":[{"name":"Department of Neonatology and Pediatric Pulmonology, Hannover Medical School, Hannover, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corinna S.","family":"Peter","sequence":"additional","affiliation":[{"name":"Department of Neonatology and Pediatric Pulmonology, Hannover Medical School, Hannover, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Do\u0308rdelmann","sequence":"additional","affiliation":[{"name":"Department of Neonatology and Pediatric Pulmonology, Hannover Medical School, Hannover, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernd","family":"Wilken","sequence":"additional","affiliation":[{"name":"Children\u2019s Hospital, Kassel, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian F.","family":"Poets","sequence":"additional","affiliation":[{"name":"Department of Neonatology, University of Tu\u0308bingen, Tu\u0308bingen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2004,4,1]]},"reference":[{"key":"2021121006164109000_R1","unstructured":"Poets CF. Apnea in premature infants. Epidemiology, pathophysiology and possibilities for prevention [in German]. Monatsschr Kinderheilkd.1993;141:558\u2013566"},{"key":"2021121006164109000_R2","doi-asserted-by":"crossref","unstructured":"Peliowski A, Finer NN. A blinded, randomized, placebo-controlled trial to compare theophylline and doxapram for the treatment of apnea of prematurity. J Pediatr.1990;116:648\u2013653","DOI":"10.1016\/S0022-3476(05)81620-8"},{"key":"2021121006164109000_R3","doi-asserted-by":"crossref","unstructured":"Martin RJ, DiFiore JM, Davis RL, Miller MJ, Coles SK, Dick TE. Persistence of the biphasic ventilatory response to hypoxia in preterm infants. J Pediatr.1998;132:960\u2013964","DOI":"10.1016\/S0022-3476(98)70391-9"},{"key":"2021121006164109000_R4","doi-asserted-by":"crossref","unstructured":"Balsom PD, So\u0308derlund K, Ekblom B. Creatine in humans with special reference to creatine supplementation. Sports Med.1994;18:268\u2013280","DOI":"10.2165\/00007256-199418040-00005"},{"key":"2021121006164109000_R5","doi-asserted-by":"crossref","unstructured":"Sahlin K, Tonkonogi M, So\u0308derlund K. Energy supply and muscle fatigue in humans. Acta Physiol Scand.1998;162:261\u2013266","DOI":"10.1046\/j.1365-201X.1998.0298f.x"},{"key":"2021121006164109000_R6","doi-asserted-by":"crossref","unstructured":"Wilken B, Ramirez JM, Probst I, Richter DW, Hanefeld F. Creatine protects the central respiratory network of mammals under anoxic conditions. Pediatr Res.1998;43:8\u201314","DOI":"10.1203\/00006450-199801000-00002"},{"key":"2021121006164109000_R7","doi-asserted-by":"crossref","unstructured":"Wilken B, Ramirez JM, Probst I, Richter DW, Hanefeld F. Anoxic ATP depletion in neonatal mice brainstem is prevented by creatine supplementation. Arch Dis Child Fetal Neonatal Ed.2000;82:F224\u2013F227","DOI":"10.1136\/fn.82.3.F224"},{"key":"2021121006164109000_R8","doi-asserted-by":"crossref","unstructured":"Azzopardi D, Wyatt J, Hamilton P, et al. Phosphorus metabolites and intracellular pH in the brains of normal and small for gestational age infants investigated by magnetic resonance spectroscopy. Pediatr Res.1989;25:440\u2013444","DOI":"10.1203\/00006450-198905000-00003"},{"key":"2021121006164109000_R9","doi-asserted-by":"crossref","unstructured":"Lopes JM, Muller NL, Bryan MH, Bryan AC. Synergistic behavior of inspiratory muscles after diaphragmatic fatigue in the newborn. J Appl Physiol.1981;51:547\u2013551","DOI":"10.1152\/jappl.1981.51.3.547"},{"key":"2021121006164109000_R10","doi-asserted-by":"crossref","unstructured":"Greenhaff PL, Bodin K, Soderlund K, Hultmann E. Effect of oral creatine supplementation on skeletal muscle phosphocreatine resynthesis. Am J Physiol.1994;266:E725\u2013E730","DOI":"10.1152\/ajpendo.1994.266.5.E725"},{"key":"2021121006164109000_R11","doi-asserted-by":"crossref","unstructured":"Harris RC, So\u0308derlund K, Hultman E. Elevation of creatine in resting and exercised muscle of normal subjects by creatine supplementation. Clin Sci (Lond).1992;83:367\u2013374","DOI":"10.1042\/cs0830367"},{"key":"2021121006164109000_R12","doi-asserted-by":"crossref","unstructured":"Stebbens VA, Poets CF, Alexander JR, Arrowsmith WA, Southall DP. Oxygen saturation and breathing patterns in infancy. 1: Full term infants in the second month of life. Arch Dis Child.1991;66:569\u2013573","DOI":"10.1136\/adc.66.5.569"},{"key":"2021121006164109000_R13","doi-asserted-by":"crossref","unstructured":"Chanutin A, Guy LP. The fate of creatine when administered to man. J Biol Chem.1926;67:29\u201341","DOI":"10.1016\/S0021-9258(18)84727-5"},{"key":"2021121006164109000_R14","doi-asserted-by":"crossref","unstructured":"Sto\u0308ckler S, Holzbach U, Hanefeld F, et al. Creatine deficiency in the brain: a new, treatable inborn error of metabolism. Pediatr Res.1994;36:409\u2013413","DOI":"10.1203\/00006450-199409000-00023"},{"key":"2021121006164109000_R15","doi-asserted-by":"crossref","unstructured":"Item CB, Sto\u0308ckler-Ipsiroglu S, Stromberger C, et al. Arginine:glycine amidinotransferase deficiency: the third inborn error of creatine metabolism in humans. Am J Genet.2001;69:1127\u20131133","DOI":"10.1086\/323765"},{"key":"2021121006164109000_R16","doi-asserted-by":"crossref","unstructured":"Wyss M, Schulze A. Health implications of creatine: can oral creatine supplementation protect against neurological and atherosclerotic disease?Neuroscience.2002;112:243\u2013260","DOI":"10.1016\/S0306-4522(02)00088-X"},{"key":"2021121006164109000_R17","doi-asserted-by":"crossref","unstructured":"Dechent P, Pouwels JW, Wilken B, Hanefeld F, Frahm J. Increase of total creatine in human brain after oral supplementation of creatine-monohydrate. Am J Physiol.1999;277:R698\u2013R704","DOI":"10.1152\/ajpregu.1999.277.3.R698"},{"key":"2021121006164109000_R18","doi-asserted-by":"crossref","unstructured":"Holtzman D, McFarland E, Moerland T, Koutcher J, Kushmerick MJ, Neuringer LJ. Brain creatine phosphate and creatine kinase in mice fed an analogue of creatine. Brain Res.1989;483:68\u201377","DOI":"10.1016\/0006-8993(89)90035-8"},{"key":"2021121006164109000_R19","unstructured":"Poets CF. Pathophysiology of Apnea of prematurity: implications from observational studies. In: Mathew OP. Respiratory Control and Its Disorders in the Newborn. New York, NY: Marcel Dekker, Inc; 2003:295\u2013316"},{"key":"2021121006164109000_R20","doi-asserted-by":"crossref","unstructured":"Jones RAK, Lukeman D. Apnoea of immaturity. 2. Mortality and handicap. Arch Dis Child.1982;57:766\u2013768","DOI":"10.1136\/adc.57.10.766"},{"key":"2021121006164109000_R21","doi-asserted-by":"crossref","unstructured":"Schmidt, B. Methylxanthine therapy in premature infants: sound practice, disaster, or fruitless byway?J Pediatr.1999;135:526\u2013528","DOI":"10.1016\/S0022-3476(99)70180-0"},{"key":"2021121006164109000_R22","unstructured":"Gesellschaft fu\u0308r Neonatologie und Pa\u0308diatrische Intensivmedizin. Leitlinie 024\/013: Therapie der idiopathischen Apnoe-Anfa\u0308lle bei Fru\u0308hgeborenen [English translation: Guideline 024\/13: Treatment of idiopathic apnea of prematurity]. Available at: http:\/\/leitlinien.net. Accessed January 25, 2004"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/113\/4\/e303\/1013244\/zpe0040400e303.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/113\/4\/e303\/1013244\/zpe0040400e303.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T14:12:54Z","timestamp":1639145574000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/113\/4\/e303\/63998\/Randomized-Controlled-Trial-of-Oral-Creatine"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4,1]]},"references-count":22,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2004,4,1]]},"published-print":{"date-parts":[[2004,4,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.113.4.e303","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"type":"print","value":"0031-4005"},{"type":"electronic","value":"1098-4275"}],"subject":[],"published":{"date-parts":[[2004,4,1]]}}}